NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Florian Hucke, Nicolás Gonzalo Núñez et al.|Nature|2021Cited by 1.3k
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Josep M. Llovet, Sasan Roayaie et al.|Journal of Hepatology|2020Cited by 301
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classificationCarla Montironi, Josep M. Llovet, Florian Castet et al.|Gut|2022Cited by 245
Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental AgentsLaura Torrens, Josep M. Llovet, Marc Puigvehí et al.|Clinical Cancer Research|2022Cited by 15
Supplementary Figure from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental AgentsLaura Torrens, Josep M. Llovet, Marc Puigvehí et al.|Unknown|2023Cited by 0